Needham analyst Mayank Tandon lowered the firm’s price target on Genpact (G) to $50 from $55 and keeps a Buy rating on the shares. The company posted solid Q1 results, beating top and bottom line estimates, and added 80 new logos, but the positive print was clouded by a weak Q2 guide and lower FY25 outlook, primarily due to heightened macro uncertainty causing large deal signings to be pushed out post “Liberation Day”, the analyst tells investors in a research note.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on G:
- Genpact price target lowered to $50 from $56 at Baird
- Genpact’s Resilience and Growth Potential Amid Economic Uncertainties: A Buy Recommendation
- Genpact’s Strategic Growth and Technological Advancements Drive Buy Rating Despite Lowered Guidance
- Genpact Sees Strong Q1 Growth in 2025
- Genpact’s Strategic Positioning Amid Timing Challenges: A Buy Opportunity
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue